AstraZeneca Russia Career For distributors Contacts Other AstraZeneca sites home About company Drugs Research Social responsibility Press center About company history of the company AstraZeneca in the world AstraZeneca in Russia Message from the head of the company Management Localization of production R&D projects in Russia List of events Contacts Are you here About company AstraZeneca in Russia AstraZeneca in Russia In 1993, representative offices of the Swedish company Astra AB and the British company Zeneca were opened in Russia. Both of them successfully worked separately from each other until 1999, when as a result of the merger of these companies on April 6, a new ambitious player appeared on the Russian pharmaceutical market - the merged AstraZeneca. Today AstraZeneca Russia is one of the most dynamic companies both in terms of the growth in the number of patients receiving treatment using its innovative drugs and in terms of sales growth. The company has its representatives in 68 cities of Russia. About 40 original products of the company are registered and approved for use in the country. AstraZeneca offers doctors and patients in Russia modern high-quality medicines, the effectiveness of which has been proven and confirmed in numerous clinical trials. The company employs about 1200 people in Russia. In the process of promoting its products, AstraZeneca is guided by high ethical standards and does everything to provide doctors and patients with the most complete and reliable information about innovative approaches to the treatment of socially significant diseases. Russia is one of the priority markets for AstraZeneca. Supporting the course of the Government of the Russian Federation for the modernization of healthcare, AstraZeneca makes a significant contribution to the Russian economy. The total contribution of AstraZeneca to the country's economy over the next 5 years will amount to $ 1.2 billion. This includes investments in production and R&D, in training and development of employees and in marketing opportunities, as well as in the further development of new channels and technologies for exchanging information with medical community. В 2011 году компания объявила о локализации производства в России для повышения доступности инновационных лекарственных средств для российских пациентов. На территории Калужской области осуществляется строительство фармацевтический фармацевтического завода полного цикла, от приготовления лекарственных форм до упаковки. Помимо локализации производства, «АстраЗенека» реализует в России широкомасштабные проекты в области поддержки исследований и разработок (R&D). As a socially responsible company, AstraZeneca implements a number of initiatives aimed at improving the health and quality of life of patients, as well as raising awareness of socially significant diseases. Among such projects are support for the World Mental Health Day and the All-Russian competition "For selfless devotion in the field of mental health", as well as participation in the unique national project "Your health is the future of Russia", the goal of which is to increase the number of diagnosed patients with high cardiovascular risk. increasing the interest of the population in their health and in the early start of treatment. Message from the President of AstraZeneca Russia more details Bookmarks & General Directory Contacts legal information Confidentiality Site Map Links © AstraZeneca 2014